3-iodobenzylguanidine has been researched along with fluorodopa f 18 in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 13 (61.90) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Carrasquillo, JA; Chen, CC; Eisenhofer, G; Goldstein, DS; Pacak, K; Whatley, M | 1 |
| Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
| Balan, KK; Brown, MJ; Chatterjee, K; Gurnell, M; Mackenzie, IS; Simpson, H | 1 |
| Barlier, A; Colavolpe, C; De Micco, C; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
| Tenenbaum, F | 1 |
| Brouwers, AH; de Jong, JR; de Vries, EG; Dierckx, RA; Elsinga, PH; Fiebrich, HB; Jager, PL; Kema, IP; Kerstens, MN; Links, TP; Pijl, ME; Sluiter, WJ; van der Wal, JE | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
| Chew, SL | 1 |
| Anlauf, M; Bartenstein, P; Fottner, C; Helisch, A; Klöppel, G; Kreft, A; Lackner, KJ; Musholt, TJ; Rossmann, H; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
| Allegri, V; Castellucci, P; di Dalmazi, G; Fanti, S; Grassi, I; Montini, GC; Nanni, C; Pagotto, U; Pasquali, R; Vicennati, V | 1 |
| Calcagni, ML; Castaldi, P; Corsello, SM; Fanti, S; Galli, G; Giordano, A; Perotti, G; Rufini, V; Treglia, G | 1 |
| Altrinetti, V; Bianchi, P; Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G | 1 |
| Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Cabria, M; Cistaro, A; Conte, M; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
| Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G | 1 |
| Guérin, C; Lowery, A; Paladino, NC; Sebag, F; Taïeb, D | 1 |
| de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M | 1 |
| Ebbehoj, A; Gormsen, LC; Poulsen, PL; Søndergaard, E | 1 |
| Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E | 1 |
| Cottereau, AS; Dousset, B; Garcia, C; Libe, R; Tenenbaum, F | 1 |
4 review(s) available for 3-iodobenzylguanidine and fluorodopa f 18
| Article | Year |
|---|---|
Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Indium Radioisotopes; Pheochromocytoma; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed | 2002 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[Adrenal incidentaloma and nuclear medicine examination].
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
17 other study(ies) available for 3-iodobenzylguanidine and fluorodopa f 18
| Article | Year |
|---|---|
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2007 |
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2008 |
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine exces
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Biomarkers; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Diagnosis: imaging of pheochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnostic Imaging; Dihydroxyphenylalanine; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transpo
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Biomarkers; Data Interpretation, Statistical; Dihydroxyphenylalanine; Female; Genetic Markers; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins; Young Adult | 2010 |
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; False Negative Reactions; Humans; Male; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paraganglioma; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2011 |
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Infant; Male; Multimodal Imaging; Neoplasm Staging; Neuroblastoma; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Characterization of neuroblastic tumors using 18F-FDOPA PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid | 2013 |
Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Dihydroxyphenylalanine; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Thoracic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Multimodality imaging of bilateral pheochromocytoma. A case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Dihydroxyphenylalanine; False Negative Reactions; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Multiple Neoplasms Simultaneously Diagnosed by Complementary Triple-Tracer PET/CT and 123I-MIBG Scintigraphy.
Topics: 3-Iodobenzylguanidine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Mutation; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2022 |